Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer

Published:2018-04 Issue:4 Volume:29 Page:1049-1055
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Guibert N.,Hu Y.,Feeney N.,Kuang Y.,Plagnol V.,Jones G.,Howarth K.,Beeler J.F.,Paweletz C.P.,Oxnard G.R.

Funder

Damon Runyon Cancer Research Foundation

U.S. Department of Defense

NCI

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/4/1049/24702550/mdy005.pdf

Reference17 articles.

1. Routine molecular profiling of patients with advanced non-small cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT);Barlesi;Lancet,2016

2. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers;Yu;Clin Cancer Res,2013

3. Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer;Sacher;JAMA Oncol,2016

4. Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small cell lung cancer;Oxnard;J Clin Oncol,2016

5. Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next-generation sequencing of cell-free circulating tumor DNA;Thompson;Clin Cancer Res,2016

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly consistency of PIK3CA mutation spectrum between circulating tumor DNA and paired tissue in lung cancer patients;Heliyon;2024-07

2. Serial Cell-Free DNA Sequencing in ROS1 Fusion–Positive Lung Cancers During Treatment With Entrectinib;JCO Precision Oncology;2024-06

3. Efficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing;Expert Review of Anticancer Therapy;2024-04-02

4. Synergistic signal amplification of a 3D Dual-Core DNA nanomachine and PCNs@AuPdCe hybrid nanozymes for ultrasensitive electrochemical detection of Cell-free DNA;Chemical Engineering Journal;2023-11

5. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGFR;Revue des Maladies Respiratoires Actualités;2023-10